Exchange: TAI Sector: Healthcare Industry: Biotechnology
-0.15% TWD34.30
America/New_York / 3 mai 2024 @ 01:30
FUNDAMENTALS | |
---|---|
MarketCap: | 3 428.29 mill |
EPS: | 1.150 |
P/E: | 29.83 |
Earnings Date: | May 10, 2024 |
SharesOutstanding: | 99.95 mill |
Avg Daily Volume: | 0.954 mill |
RATING 2024-05-03 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
1.61x |
Company: PE 29.83 | sector: PE 18.55 |
PE RATIO: COMPANY / INDUSTRY |
---|
2.19x |
Company: PE 29.83 | industry: PE 13.63 |
DISCOUNTED CASH FLOW VALUE |
---|
TWD40.63 (18.47%) TWD6.33 |
Date: 2024-05-04 |
Expected Trading Range (DAY) |
---|
TWD 33.11 - 35.49 ( +/- 3.47%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | TWD34.30 (-0.15% ) |
Volume | 0.484 mill |
Avg. Vol. | 0.954 mill |
% of Avg. Vol | 50.79 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residues check systems; and care management and tele-health services. The company was founded in 1997 and is headquartered in Hsinchu City, Taiwan.